Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma
- Author(s)
- Chakraborty, R; Cheruvalath, H; Patwari, A; Szabo, A; Schinke, C; Dhakal, B; Lentzsch, S; D'Souza, A; Mohyuddin, GR; Julian, K; Midha, S; Costello, P; Kaiser, M; Hing, MNL; Harrison, SJ; Cliff, ERS; Mohan, M;
- Details
- Publication Year 2024,Volume 14,Issue #1,Page 137
- Journal Title
- Blood Cancer Journal
- Publication Type
- Research article
- Publisher
- Springer Nature
- Keywords
- Humans; *Multiple Myeloma/drug therapy/immunology/therapy; *Antibodies, Bispecific/therapeutic use; Female; Male; Middle Aged; Aged; Remission Induction; Antineoplastic Agents, Immunological/therapeutic use; Neoplasm Recurrence, Local/drug therapy; Adult; Treatment Outcome
- Department(s)
- Clinical Haematology
- Publisher's Version
- https://doi.org/10.1038/s41408-024-01114-7
- Open Access at Publisher's Site
https://doi.org/10.1038/s41408-024-01114-7- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-09-10 04:36:50
Last Modified: 2024-09-10 04:41:31